These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 6383922)
21. Direct effects of cyclosporin A on human pancreatic beta-cells. Nielsen JH; Mandrup-Poulsen T; Nerup J Diabetes; 1986 Sep; 35(9):1049-52. PubMed ID: 3527825 [TBL] [Abstract][Full Text] [Related]
22. Effect of prolonged administration of cyclosporin A on (pro)insulin biosynthesis and insulin release by rat islets of Langerhans. Chandrasekar B; Mukherjee SK Biochem Pharmacol; 1988 Oct; 37(19):3609-11. PubMed ID: 3052458 [TBL] [Abstract][Full Text] [Related]
23. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. Eizirik DL; Korbutt GS; Hellerström C J Clin Invest; 1992 Oct; 90(4):1263-8. PubMed ID: 1401063 [TBL] [Abstract][Full Text] [Related]
24. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta. Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106 [TBL] [Abstract][Full Text] [Related]
25. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes. Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346 [TBL] [Abstract][Full Text] [Related]
26. Cycad toxin-induced damage of rodent and human pancreatic beta-cells. Eizirik DL; Kisby GE Biochem Pharmacol; 1995 Jul; 50(3):355-65. PubMed ID: 7646537 [TBL] [Abstract][Full Text] [Related]
27. Effects of growth hormone, prolactin, and placental lactogen on insulin content and release, and deoxyribonucleic acid synthesis in cultured pancreatic islets. Nielsen JH Endocrinology; 1982 Feb; 110(2):600-6. PubMed ID: 6276141 [TBL] [Abstract][Full Text] [Related]
28. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Lau T; Carlsson PO; Leung PS Diabetologia; 2004 Feb; 47(2):240-8. PubMed ID: 14722647 [TBL] [Abstract][Full Text] [Related]
29. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice. Strandell E; Sandler S J Endocrinol; 1997 Apr; 153(1):81-6. PubMed ID: 9135572 [TBL] [Abstract][Full Text] [Related]
30. Exposure of rat pancreatic islets to RS-61443 inhibits beta-cell function. Sandberg JO; Andersson A; Sandler S Transplantation; 1993 Nov; 56(5):1197-201. PubMed ID: 8249122 [TBL] [Abstract][Full Text] [Related]
31. Prolonged exposure of pancreatic islets isolated from "pre-diabetic" non-obese diabetic mice to a high glucose concentration does not impair beta-cell function. Eizirik DL; Strandell E; Sandler S Diabetologia; 1991 Jan; 34(1):6-11. PubMed ID: 2055343 [TBL] [Abstract][Full Text] [Related]
32. Effects of cyclosporin A and verapamil on mouse pancreatic islets. Shi CL; Rooth P; Täljedal IB Acta Endocrinol (Copenh); 1993 Jul; 129(1):54-8. PubMed ID: 8351959 [TBL] [Abstract][Full Text] [Related]
33. Defective catabolism of D-glucose and L-glutamine in mouse pancreatic islets maintained in culture after streptozotocin exposure. Eizirik DL; Sandler S; Sener A; Malaisse WJ Endocrinology; 1988 Aug; 123(2):1001-7. PubMed ID: 2969323 [TBL] [Abstract][Full Text] [Related]
34. Cryopreservation of mouse pancreatic islets. Effects of fast cooling on islet B cell function and on the outcome of islet transplantation. Sandler S; Kojima Y; Andersson A Transplantation; 1986 Dec; 42(6):588-93. PubMed ID: 3097892 [TBL] [Abstract][Full Text] [Related]
35. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo. Sternesjö J; Welsh N; Sandler S Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135 [TBL] [Abstract][Full Text] [Related]
36. Intravenous glucose tolerance and pancreatic islet beta-cell function in patients with multiple sclerosis during 2-yr treatment with cyclosporin. Robertson RP; Franklin G; Nelson L Diabetes; 1989 Jan; 38(1):58-64. PubMed ID: 2642435 [TBL] [Abstract][Full Text] [Related]
37. Adaptive response in beta-cell function in pancreatic islets isolated from partially pancreatectomized rats. Sandler S; Jansson L; Welsh N Mol Cell Endocrinol; 1992 Aug; 86(3):149-56. PubMed ID: 1511784 [TBL] [Abstract][Full Text] [Related]
38. The action of cyclosporin A on the endocrine pancreas in vitro--functional and morphological studies. Laube F; Blech W; Schröder D; Besch W; Hildebrandt W; Hahn HJ Exp Clin Endocrinol; 1986 Jun; 87(1):69-78. PubMed ID: 3527725 [TBL] [Abstract][Full Text] [Related]
39. Reversal of beta-cell suppression in vitro in pancreatic islets isolated from nonobese diabetic mice during the phase preceding insulin-dependent diabetes mellitus. Strandell E; Eizirik DL; Sandler S J Clin Invest; 1990 Jun; 85(6):1944-50. PubMed ID: 2189896 [TBL] [Abstract][Full Text] [Related]
40. Functional characteristics of cultured mouse pancreatic islets following exposure to different streptozotocin concentrations. Strandell E; Eizirik DL; Korsgren O; Sandler S Mol Cell Endocrinol; 1988 Sep; 59(1-2):83-91. PubMed ID: 2974003 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]